↓ SCROLL TO SEE MORE ↑

What are you looking for?

News

EMA said on Monday that it has begun evaluating an application by Pfizer for its anti-coronavirus drug Paxlovid

EMA said on Monday that it has begun evaluating an application by Pfizer for its anti-coronavirus drug Paxlovid

“EMA has started evaluating an application for a conditional marketing authorization for the oral antiviral medicine Paxlovid,” the EU regulator said in a statement.

The statement said that the regulator could deliver its assessment within weeks since it had already carried out a preliminary review based on laboratory, animal, and clinical studies.

Following EMA’s recommendation, the European Commission would officially give the marketing authorization.

The medicine reduces the ability of the virus to multiply in the body.

By treating adults and adolescents with mild-to-moderate symptoms of COVID-19, the drug can lower the risk of developing severe illness and hospitalization.

News

The first monkeypox case in Türkiye was confirmed on Thursday. “Monkeypox was detected in one of our patients. The patient is 37 years old,...

News

Prime Minister Hun Sen’s Friday warned to jail those responsible for spreading fake news. “Please do not take the COVID-19 issue as a joke,...

News

A group of Turkish scientists applied to health authorities for human trials of an innovative nasal spray developed against COVID-19 and influenza. Animal trials...

News

Cities and coastal resorts in Turkey are gearing up for an influx of travelers now that Turkey has extended the upcoming religious holiday, in...